Venetoclax Tablets approval has been granted by the USFDA, signaling a significant advancement in cancer treatment options.
Month: October 2026
FDA Drug Approval: Is It the Worst Decision Ever?
FDA drug approval is under scrutiny as the agency considers revoking its endorsement. What does this mean for patients?
FDA Approval Pancreatic Cancer Pill: Is Price Worth It?
FDA approval pancreatic cancer pill raises questions about its high price.
Alembic Pharmaceuticals Approval: Safe and Proven Ear Drug
Alembic Pharmaceuticals approval marks a significant milestone for ear infection treatment with USFDA’s final approval.
Cancer drug price cuts: Are they the best deal for patients?
Cancer drug price cuts are set to provide significant savings for patients starting November 9.
Karnataka Medicine Pricing: Clear Rules for MRP Disclosure
Karnataka medicine pricing regulations require landing price and MRP disclosure on bills starting November 1, ensuring transparency for consumers.
Prostate Cancer Drug Approval: Hengrui Pharma’s New Hope
Prostate cancer drug approval has been achieved by Hengrui Pharma, promising new treatment options for patients in Europe.
Deep Health AI India Secures Smart Debt Acquisition Deal
Deep Health AI India has approved a ₹10.35 crore debt acquisition from Kshitij Polyline, marking a significant financial move.




